New protein injection shows promise for Alzheimer's in early trial
Disease control
Ongoing
This early-stage study tests whether a lab-made version of a natural blood protein (rHSA) is safe and can help people with mild to moderate Alzheimer's. Thirty adults aged 50-85 will receive one of three doses (20g, 30g, or 40g) and be monitored for about 6 months. The main goal …
Phase: EARLY_PHASE1 • Sponsor: Protgen Ltd • Aim: Disease control
Last updated Apr 24, 2026 16:18 UTC